Bank of New York Mellon’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.85M | Sell |
114,067
-4,480
| -4% | -$79.3K | ﹤0.01% | 2849 |
|
|
2025
Q4 | $2.22M | Buy |
118,547
+3,977
| +3% | +$66K | ﹤0.01% | 2772 |
|
|
2025
Q3 | $1.67M | Buy |
114,570
+4,024
| +4% | +$50.9K | ﹤0.01% | 2910 |
|
|
2025
Q2 | $1.22M | Sell |
110,546
-6,953
| -6% | -$67.6K | ﹤0.01% | 3020 |
|
|
2025
Q1 | $1.05M | Buy |
117,499
+1,720
| +1% | +$16K | ﹤0.01% | 3038 |
|
|
2024
Q4 | $1.09M | Sell |
115,779
-5,282
| -4% | -$48.1K | ﹤0.01% | 3105 |
|
|
2024
Q3 | $976K | Sell |
121,061
-29,911
| -20% | -$259K | ﹤0.01% | 3146 |
|
|
2024
Q2 | $1.28M | Sell |
150,972
-11,056
| -7% | -$99.8K | ﹤0.01% | 3054 |
|
|
2024
Q1 | $1.45M | Sell |
162,028
-34,356
| -17% | -$318K | ﹤0.01% | 2944 |
|
|
2023
Q4 | $2.21M | Sell |
196,384
-6,929
| -3% | -$69.7K | ﹤0.01% | 2781 |
|
|
2023
Q3 | $1.75M | Sell |
203,313
-12,840
| -6% | -$124K | ﹤0.01% | 2885 |
|
|
2023
Q2 | $2.24M | Buy |
216,153
+6,139
| +3% | +$67.8K | ﹤0.01% | 2770 |
|
|
2023
Q1 | $2.28M | Sell |
210,014
-1,582
| -0.7% | -$16.7K | ﹤0.01% | 2723 |
|
|
2022
Q4 | $2.37M | Buy |
211,596
+6,126
| +3% | +$64.4K | ﹤0.01% | 2757 |
|
|
2022
Q3 | $2.08M | Buy |
205,470
+23,555
| +13% | +$221K | ﹤0.01% | 2820 |
|
|
2022
Q2 | $1.65M | Sell |
181,915
-7,782
| -4% | -$71.7K | ﹤0.01% | 2943 |
|
|
2022
Q1 | $1.81M | Buy |
189,697
+1,371
| +0.7% | +$13.4K | ﹤0.01% | 2985 |
|
|
2021
Q4 | $2.08M | Buy |
188,326
+11,905
| +7% | +$104K | ﹤0.01% | 2971 |
|
|
2021
Q3 | $1.31M | Buy |
176,421
+1,062
| +0.6% | +$11.9K | ﹤0.01% | 3243 |
|
|
2021
Q2 | $2.55M | Sell |
175,359
-26,950
| -13% | -$506K | ﹤0.01% | 2843 |
|
|
2021
Q1 | $4.13M | Sell |
202,309
-3,771
| -2% | -$71.7K | ﹤0.01% | 2530 |
|
|
2020
Q4 | $3.66M | Sell |
206,080
-4,895
| -2% | -$87.9K | ﹤0.01% | 2508 |
|
|
2020
Q3 | $3.12M | Sell |
210,975
-4,340
| -2% | -$81.3K | ﹤0.01% | 2438 |
|
|
2020
Q2 | $4.52M | Buy |
215,315
+4,347
| +2% | +$112K | ﹤0.01% | 2251 |
|
|
2020
Q1 | $4.88M | Buy |
210,968
+7,600
| +4% | +$190K | ﹤0.01% | 2093 |
|
|
2019
Q4 | $5.26M | Buy |
203,368
+6,097
| +3% | +$118K | ﹤0.01% | 2320 |
|
|
2019
Q3 | $3.84M | Sell |
197,271
-10,572
| -5% | -$214K | ﹤0.01% | 2406 |
|
|
2019
Q2 | $3.39M | Sell |
207,843
-1,366
| -0.7% | -$27.7K | ﹤0.01% | 2521 |
|
|
2019
Q1 | $4.74M | Buy |
209,209
+1,092
| +0.5% | +$27.7K | ﹤0.01% | 2356 |
|
|
2018
Q4 | $5.33M | Buy |
208,117
+2,547
| +1% | +$68.8K | ﹤0.01% | 2250 |
|
|
2018
Q3 | $6.72M | Sell |
205,570
-520
| -0.3% | -$14.2K | ﹤0.01% | 2256 |
|
|
2018
Q2 | $4.67M | Sell |
206,090
-3,817
| -2% | -$90.6K | ﹤0.01% | 2428 |
|
|
2018
Q1 | $5.09M | Sell |
209,907
-774
| -0.4% | -$21.3K | ﹤0.01% | 2344 |
|
|
2017
Q4 | $5.88M | Buy |
210,681
+350
| +0.2% | +$10.4K | ﹤0.01% | 2280 |
|
|
2017
Q3 | $7.2M | Buy |
210,331
+2,624
| +1% | +$85.8K | ﹤0.01% | 2164 |
|
|
2017
Q2 | $8.27M | Buy |
207,707
+1,684
| +0.8% | +$64.7K | ﹤0.01% | 2077 |
|
|
2017
Q1 | $7.59M | Buy |
206,023
+5,188
| +3% | +$166K | ﹤0.01% | 2103 |
|
|
2016
Q4 | $6.4M | Sell |
200,835
-21,009
| -9% | -$652K | ﹤0.01% | 2187 |
|
|
2016
Q3 | $8.04M | Buy |
221,844
+42,075
| +23% | +$1.17M | ﹤0.01% | 1980 |
|
|
2016
Q2 | $4.08M | Buy |
179,769
+36,397
| +25% | +$786K | ﹤0.01% | 2318 |
|
|
2016
Q1 | $2.69M | Buy |
143,372
+2,752
| +2% | +$45K | ﹤0.01% | 2485 |
|
|
2015
Q4 | $2.31M | Buy |
140,620
+12,004
| +9% | +$191K | ﹤0.01% | 2632 |
|
|
2015
Q3 | $1.41M | Sell |
128,616
-735
| -0.6% | -$9.36K | ﹤0.01% | 2961 |
|
|
2015
Q2 | $1.68M | Buy |
129,351
+10,357
| +9% | +$161K | ﹤0.01% | 3033 |
|
|
2015
Q1 | $2.06M | Buy |
118,994
+2,486
| +2% | +$45.6K | ﹤0.01% | 2841 |
|
|
2014
Q4 | $1.74M | Sell |
116,508
-3,989
| -3% | -$69.5K | ﹤0.01% | 2956 |
|
|
2014
Q3 | $2.78M | Buy |
120,497
+372
| +0.3% | +$10.8K | ﹤0.01% | 2650 |
|
|
2014
Q2 | $3.83M | Buy |
+120,125
| New | +$3.62M | ﹤0.01% | 2480 |
|
Other funds holding TBPH
MAP
WAM
NM
ICM
VCM
